2-tert-Butyl 5-ethyl 3,4-dihydro-2,7-naphthyridine-2,5(1H)-dicarboxylate

Catalog No. :
ACQSFL882
CAS No. :
1330764-93-6
Molecular Formula :
C16H22N2O4
Molecular Weight :
306.36

IUPAC Name:2-(tert-butyl) 5-ethyl 3,4-dihydro-2,7-naphthyridine-2,5(1H)-dicarboxylate

2-tert-Butyl 5-ethyl 3,4-dihydro-2,7-naphthyridine-2,5(1H)-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$617.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-tert-Butyl 5-ethyl 3,4-dihydro-2,7-naphthyridine-2,5(1H)-dicarboxylate
IUPAC Name2-(tert-butyl) 5-ethyl 3,4-dihydro-2,7-naphthyridine-2,5(1H)-dicarboxylate
MDL No.MFCD20231179
Molecular FormulaC16H22N2O4
Molecular Weight306.36
SMILESO=C(N1CC2=CN=CC(C(OCC)=O)=C2CC1)OC(C)(C)C
InChI KeyZHNNGEYRNANOCS-UHFFFAOYSA-N
Synonym2-Tert-Butyl 5-Ethyl 3,4-Dihydro-2,7-Naphthyridine-2,5(1H)-Dicarboxylate;2-Tert-Butyl 5-Ethyl 3,4-Dihydro-2,7-Naphthyridine-2,5(1H)-Dicarboxylate(WX141016);2,7-Naphthyridine-2,5(1H)-dicarboxylic acid, 3,4-dihydro-, 2-(1,1-dimethylethyl) 5-ethyl ester
CAS No.1330764-93-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQSFL882 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQSFL882 route product structure diagram
    ACQSFL8821330764-93-6
Inquiry

2. ACQSFL882 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQSFL882 route product structure diagram
    ACQSFL8821330764-93-6
Inquiry

Comments (0)